ID
21977
Description
An International, Randomized, Double-Blind, Placebo-Controlled Study of Valaciclovir for the Suppression and Episodic Treatment of Genital HSV Infection in HIV-Infected Persons with CD4+ lymphocyte count <100 cells/mm3
Keywords
Versions (1)
- 5/12/17 5/12/17 -
Uploaded on
May 12, 2017
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Demography GlaxoSmithKline Study of Valaciclovir for the Suppression and Episodic Treatment of Genital HSV Infection in HIV-Infected Persons
GlaxoSmithKline Study of Valaciclovir for the Suppression and Episodic
Description
Demography
Alias
- UMLS CUI-1
- C0011298
Description
Date of birth
Data type
date
Measurement units
- DD-MMM-YYYY
Alias
- UMLS CUI [1]
- C0421451
Description
Sex
Data type
text
Alias
- UMLS CUI [1]
- C0079399
Description
*See facing page for race definitions.
Data type
integer
Alias
- UMLS CUI [1]
- C0034510
Description
Vital Signs
Description
Randomisation Number
Similar models
GlaxoSmithKline Study of Valaciclovir for the Suppression and Episodic
C0237753 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])
No comments